An involvement of macrophages in the anti-tumour effect of IL-18 is further supported by the finding that intratumoral injection of rIL-18 into subcutaneous tumours elevated serum levels of MCP-1 (Fig. 6 E). The gene discussed is CCL2; the disease is neoplasm.